Skip to main content

Anemia in Liver Disease

  • Chapter
  • First Online:
Management of Anemia

Abstract

Multiple different types of anemia are associated with liver disease. Portal hypertension related to chronic or acute liver disease may cause gastrointestinal bleeding, which is predisposed by coagulopathy related to liver dysfunction. Acute blood loss anemia in these circumstances is often due to gastroesophageal varices, which also may lead to iron-deficiency anemia with repeated episodes. In addition, chronic bleeding sources in the liver patient include gastrointestinal vascular ectasia and portal hypertensive gastropathy. Liver disease is associated with abnormalities in the composition of red blood cell membranes, leading to variant cells that are prone to hemolysis and splenic consumption, particularly in the setting of hypersplenism. Multiple distinct types of liver disease are associated with anemia, ranging from viral hepatitis-associated aplastic anemia to hemolytic anemia associated with copper accumulation in Wilson’s disease. Excessive alcohol use as well may cause anemia through a variety of mechanisms, including spur cell anemia and bone marrow suppression. Treatment regimens for hepatitis C which utilize ribavirin and pegylated interferon also frequently have anemia as a side effect that often necessitates therapy adjustment. Chronic liver disease may also result in nutrient deficiencies that impair and limit effective bone marrow erythropoiesis. Several different varieties of anemia occur through a myriad of mechanisms in the setting of liver disease and dysfunction that require astute recognition by clinicians.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–38.

    Article  CAS  PubMed  Google Scholar 

  2. Sikuler E, Groszmann RJ. Interaction of flow and resistance in maintenance of portal hypertension in a rat model. Am J Phys. 1986;250(2 Pt 1):G205–12.

    CAS  Google Scholar 

  3. Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol. 2009;15(37):4653–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Urrunaga NH, Rockey DC. Portal hypertensive gastropathy and colopathy. Clin Liver Dis. 2014;18(2):389–406.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Perez-Ayuso RM, Pique JM, Bosch J, Panes J, Gonzalez A, Perez R, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet. 1991;337(8755):1431–4.

    Article  CAS  PubMed  Google Scholar 

  6. Thuluvath PJ, Yoo HY. Portal hypertensive gastropathy. Am J Gastroenterol. 2002;97(12):2973–8.

    Article  PubMed  Google Scholar 

  7. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33(5):846–52.

    Article  PubMed  Google Scholar 

  8. Hosking SW, Kennedy HJ, Seddon I, Triger DR. The role of propranolol in congestive gastropathy of portal hypertension. Hepatology. 1987;7(3):437–41.

    Article  CAS  PubMed  Google Scholar 

  9. Zhou Y, Qiao L, Wu J, Hu H, Xu C. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. J Gastroenterol Hepatol. 2002;17(9):973–9.

    Article  CAS  PubMed  Google Scholar 

  10. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53(4):762–8.

    Article  PubMed  Google Scholar 

  11. Patwardhan VR, Cardenas A. Review article: the management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis. Aliment Pharmacol Ther. 2014;40(4):354–62.

    Article  CAS  PubMed  Google Scholar 

  12. Cho S, Zanati S, Yong E, Cirocco M, Kandel G, Kortan P, et al. Endoscopic cryotherapy for the management of gastric antral vascular ectasia. Gastrointest Endosc. 2008;68(5):895–902.

    Article  PubMed  Google Scholar 

  13. Holzbach RT, Shipley RA, Clark RE, Chudzik EB. Influence of spleen size and portal pressure on erythrocyte sequestration. J Clin Invest. 1964;43:1125–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kedia S, Goyal R, Mangla V, Kumar A, S S, Das P, et al. Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, child’s status and institution of specific treatment for hepatitis C with success. Ann Hepatol. 2012;11(6):921–9.

    PubMed  Google Scholar 

  15. Lee CM, Leung TK, Wang HJ, Lee WH, Shen LK, Liu JD, et al. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol. 2007;13(4):619–22.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Cooper RA. Hemolytic syndromes and red cell membrane abnormalities in liver disease. Semin Hematol. 1980;17(2):103–12.

    CAS  PubMed  Google Scholar 

  17. Vassiliadis T, Mpoumponaris A, Vakalopoulou S, Giouleme O, Gkissakis D, Grammatikos N, et al. Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: incidence and correlation with disease severity and survival. Hepatol Res. 2010;40(2):161–70.

    Article  PubMed  Google Scholar 

  18. Jandl JH. The anemia of liver disease: observations on its mechanism. J Clin Invest. 1955;34(3):390–404.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Owen JS, Brown DJ, Harry DS, McIntyre N, Beaven GH, Isenberg H, et al. Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins. J Clin Invest. 1985;76(6):2275–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Morse EE. Mechanisms of hemolysis in liver disease. Ann Clin Lab Sci. 1990;20(3):169–74.

    CAS  PubMed  Google Scholar 

  21. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8):2509–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia. N Engl J Med. 1997;336(15):1059–64.

    Article  CAS  PubMed  Google Scholar 

  23. Gonzalez-Casas R, Garcia-Buey L, Jones EA, Gisbert JP, Moreno-Otero R. Systematic review: hepatitis-associated aplastic anaemia—a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther. 2009;30(5):436–43.

    Article  CAS  PubMed  Google Scholar 

  24. Hibbs JR, Frickhofen N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A, et al. Aplastic anemia and viral hepatitis. Non-A, non-B, non-C? JAMA. 1992;267(15):2051–4.

    Article  CAS  PubMed  Google Scholar 

  25. Cattral MS, Langnas AN, Markin RS, Antonson DL, Heffron TG, Fox IJ, et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology. 1994;20(4 Pt 1):813–8.

    Article  CAS  PubMed  Google Scholar 

  26. Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147(1):43–70.

    Article  CAS  PubMed  Google Scholar 

  27. Savage D, Lindenbaum J. Anemia in alcoholics. Medicine. 1986;65(5):322–38.

    Article  CAS  PubMed  Google Scholar 

  28. Conrad ME, Barton JC. Anemia and iron kinetics in alcoholism. Semin Hematol. 1980;17(3):149–63.

    CAS  PubMed  Google Scholar 

  29. Malik P, Bogetti D, Sileri P, Testa G, Blumenthal SA, Wiley TE, et al. Spur cell anemia in alcoholic cirrhosis: cure by orthotopic liver transplantation and recurrence after liver graft failure. Int Surg. 2002;87(4):201–4.

    PubMed  Google Scholar 

  30. Zieve L. Jaundice, hyperlipemia and hemolytic anemia: a heretofore unrecognized syndrome associated with alcoholic fatty liver and cirrhosis. Ann Intern Med. 1958;48(3):471–96.

    Article  CAS  PubMed  Google Scholar 

  31. Sharma S, Toppo A, Rath B, Harbhajanka A, Lalita JP. Hemolytic anemia as a presenting feature of Wilson’s disease: a case report. Indian J Hematol Blood Transfus. 2010;26(3):101–2.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Grudeva-Popova JG, Spasova MI, Chepileva KG, Zaprianov ZH. Acute hemolytic anemia as an initial clinical manifestation of Wilson’s disease. Folia Med. 2000;42(2):42–6.

    CAS  Google Scholar 

  33. Roche-Sicot J, Benhamou JP. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson’s disease. Ann Intern Med. 1977;86(3):301–3.

    Article  CAS  PubMed  Google Scholar 

  34. Saito T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr. 1987;146(3):261–5.

    Article  CAS  PubMed  Google Scholar 

  35. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47(6):2089–111.

    Article  CAS  PubMed  Google Scholar 

  36. Arnon R, Annunziato R, Schilsky M, Miloh T, Willis A, Sturdevant M, et al. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transpl. 2011;25(1):E52–60.

    Article  Google Scholar 

  37. De Franceschi L, Fattovich G, Turrini F, Ayi K, Brugnara C, Manzato F, et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology. 2000;31(4):997–1004.

    Article  PubMed  Google Scholar 

  38. de-la-Serna Higuera C, Barcena-Marugan R, Sanz-de-Villalobos E. Hemolytic anemia secondary to alpha-interferon treatment in a patient with chronic C hepatitis. J Clin Gastroenterol. 1999;28(4):358–9.

    Article  CAS  PubMed  Google Scholar 

  39. Dieterich DT, Wasserman R, Brau N, Hassanein TI, Bini EJ, Bowers PJ, et al. Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa. Am J Gastroenterol. 2003;98(11):2491–9.

    CAS  PubMed  Google Scholar 

  40. Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013;368(20):1878–87.

    Article  CAS  PubMed  Google Scholar 

  41. Koretz RL, Avenell A, Lipman TO. Nutritional support for liver disease. Cochrane Database Syst Rev. 2012;5:CD008344.

    Google Scholar 

  42. McClain CJ, Barve SS, Barve A, Marsano L. Alcoholic liver disease and malnutrition. Alcohol Clin Exp Res. 2011;35(5):815–20.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Caregaro L, Alberino F, Amodio P, Merkel C, Bolognesi M, Angeli P, et al. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr. 1996;63(4):602–9.

    CAS  PubMed  Google Scholar 

  44. Spengler EK, Dunkelberg J, Schey R. Alcoholic hepatitis: current management. Dig Dis Sci. 2014;59(10):2357–66.

    Article  CAS  PubMed  Google Scholar 

  45. DiCecco SR, Wieners EJ, Wiesner RH, Southorn PA, Plevak DJ, Krom RA. Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. Mayo Clin Proc. 1989;64(1):95–102.

    Article  CAS  PubMed  Google Scholar 

  46. Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig. 1992;70(6):478–86.

    Article  CAS  PubMed  Google Scholar 

  47. Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr. 1996;16:179–203.

    Article  CAS  PubMed  Google Scholar 

  48. de Carvalho SC, Muniz MT, Siqueira MD, Siqueira ER, Gomes AV, Silva KA, et al. Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD). Nutr J. 2013;12:37.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Fragasso A, Mannarella C, Ciancio A, Scarciolla O, Nuzzolese N, Clemente R, et al. Holotranscobalamin is a useful marker of vitamin B12 deficiency in alcoholics. ScientificWorld J. 2012;2012:128182.

    Article  Google Scholar 

  50. Medici V, Halsted CH. Folate, alcohol, and liver disease. Mol Nutr Food Res. 2013;57(4):596–606.

    Article  CAS  PubMed  Google Scholar 

  51. Herbert V, Zalusky R, Davidson CS. Correlation of folate deficiency with alcoholism and associated macrocytosis, anemia, and liver disease. Ann Intern Med. 1963;58:977–88.

    Article  CAS  PubMed  Google Scholar 

  52. Fernando OV, Grimsley EW. Prevalence of folate deficiency and macrocytosis in patients with and without alcohol-related illness. South Med J. 1998;91(8):721–5.

    Article  CAS  PubMed  Google Scholar 

  53. Halsted CH, Villanueva J, Chandler CJ, Stabler SP, Allen RH, Muskhelishvili L, et al. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation. Hepatology. 1996;23(3):497–505.

    Article  CAS  PubMed  Google Scholar 

  54. Wani NA, Kaur J. Reduced levels of folate transporters (PCFT and RFC) in membrane lipid rafts result in colonic folate malabsorption in chronic alcoholism. J Cell Physiol. 2011;226(3):579–87.

    Article  CAS  PubMed  Google Scholar 

  55. Eichner ER, Hillman RS. The evolution of anemia in alcoholic patients. Am J Med. 1971;50(2):218–32.

    Article  CAS  PubMed  Google Scholar 

  56. Halsted CH, Villanueva JA, Devlin AM, Niemela O, Parkkila S, Garrow TA, et al. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc Natl Acad Sci U S A. 2002;99(15):10072–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew J. Muir M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Patel, Y.A., Kappus, M.R., Muir, A.J. (2018). Anemia in Liver Disease. In: Provenzano, R., Lerma, E., Szczech, L. (eds) Management of Anemia. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7360-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7360-6_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-7358-3

  • Online ISBN: 978-1-4939-7360-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics